Leptin and leptin receptor gene polymorphisms and their association with plasma leptin levels and obesity in a multi-ethnic Malaysian suburban population by Sook-Ha Fan & Yee-How Say
Fan and Say Journal of Physiological Anthropology 2014, 33:15
http://www.jphysiolanthropol.com/content/33/1/15ORIGINAL ARTICLE Open AccessLeptin and leptin receptor gene polymorphisms
and their association with plasma leptin levels
and obesity in a multi-ethnic Malaysian suburban
population
Sook-Ha Fan and Yee-How Say*Abstract
Background: This study was to investigate the prevalence of single nucleotide polymorphisms (SNPs) in leptin
gene LEP (A19G and G2548A) and leptin receptor gene LEPR (K109R and Q223R) and their association with fasting
plasma leptin level (PLL) and obesity in a Malaysian suburban population in Kampar, Perak.
Methods: Convenience sampling was performed with informed consents, and the study sample was drawn from
patients who were patrons of the Kampar Health Clinic. A total of 408 subjects (mean age, 52.4 ± 13.7 years; 169
men, 239 women; 190 obese, 218 non-obese; 148 Malays, 177 ethnic Chinese, 83 ethnic Indians) participated.
Socio-demographic data and anthropometric measurements were taken, and genotyping was performed using
polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP).
Results: The LEP A19G, G2548A and LEPR K109R, Q223R variant allele frequencies were 0.74, 0.67 and 0.61, 0.79,
respectively. The genotype and allele distributions of these gene variants were significantly different among ethnic
groups, but not among body mass index (BMI) classes. Subjects with LEPR K109 and Q223 allele had significantly
higher systolic blood pressure and adiposity indices after adjustment for ethnicity (higher BMI, total body and
subcutaneous fat; lower skeletal muscle percentage). Subjects with LEPR 109R allele had lower PLL than their
wild-type allele counterparts. The influence of LEP A19G and G2548A SNPs on blood pressures, anthropometrics,
and PLL was not evident. Interestingly, synergistic effect of the LEP and LEPR SNPs was observed as subjects
homozygous for all four SNPs studied exhibited significantly higher subcutaneous fat and PLL than those with other
genotype combinations.
Conclusions: The LEP and LEPR SNPs in this study may not be an obesity marker among Malaysians in this
population, but were associated with ethnicity. Our findings suggest that each of these SNPs contributes to minor
but significant variation in obesity-related traits and in combination they display synergistic effects on subcutaneous
fat and PLL.
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Obesity is defined as excessive fat accumulation in the
body caused by an imbalance of energy between caloric
consumption and expenditure [1]. The etiology of obesity
is multifactorial as it involves genetic and environmental
factors as well as the complex interactions among them
[2]. The prevalence of obesity is rising at an alarming rate
worldwide to the extent that it is currently considered a
pandemic rather than epidemic. The Malaysian Fourth
National Health and Morbidity Survey (NHMS IV) con-
ducted in 2011 reported that the prevalence of overweight
and obese has increased from 29.1% to 29.4% and 14.0%
to 15.1%, respectively [3]. One of the most important
routes involved in regulating body weight and energy ex-
penditure is the leptin-melanocortin signaling pathway.
Leptin, an adipocyte-derived hormone, acts as a satiety
signal by downregulating orexigenic peptides (neuropeptide
Y, agouti-gene related peptide, melanin-concentrating hor-
mone, and orexin) which stimulate appetite and upregulat-
ing anorexigenic peptides (alpha-melanocyte stimulating
hormone, cocaine and amphetamine-regulated transcripts,
and corticotropin-releasing hormone) which inhibit feeding
[4]. Leptin exerts its physiological effect by binding to leptin
receptor, a single transmembrane protein which belongs to
class I cytokine receptor family. Of all the LEPR isoforms
described so far, the long isoform LEPRb is of physiological
importance [4]. Upon leptin binding to its receptor, a
LEPRb/Janus kinase 2 (JAK2) complex is formed, resulting
in cross-phosporylation. The tyrosine residue, Tyr1138 on
LEPRb is important for signal transducer and activator of
transcription 3 (STAT3) activation, which activates sup-
pressor of cytokine signaling 3 (SOCS3) expression. This
leads to negative inhibition of leptin signaling through
Tyr985 and additional sites on JAK2. Mitogen-activated
protein kinase (MAPK) and insulin receptor substrate/
phosphatidyl-inositol 3’ kinase (PI3K) pathways can be ac-
tivated following JAK2 phosphorylation [4].
Several polymorphisms of both the genes were studied
in different populations for its potential association with
obesity and its related complications. Among these vari-
ants, the LEP A19G and G2548A as well as LEPR K109R
and Q223R single nucleotide polymorphisms (SNPs) have
been studied in detail. These findings were replicated
across different populations, revealing contradictory find-
ings. Most literature to date regarding the association be-
tween obesity and these polymorphisms are less clear and
notably scarce in non-Caucasian populations. The lack of
data on this subject emphasizes the need for studies among
Malaysians and also across ethnic groups.
In the present study, we determined the prevalence of
the LEP A19G, LEP G2548A, LEPR K109R, and LEPR
Q223R SNPs and its possible association with obesity
and its related traits in a Malaysian multi-ethnic subur-
ban population in Kampar, Perak.Methods
Subjects and anthropometric measurements
According to the 2010 population and housing census
[5], the population size in Kampar was 88,638 with a ra-
tio of 3:5:1 for the Malays, Chinese, and Indians while the
ratio of the subjects in this study was 2:2:1. The higher
number of Chinese in the Kampar population census
could be due to the inclusion of college/university stu-
dents (Kolej Tunku Abdul Rahman/Universiti Tunku
Abdul Rahman, Perak campus) which are predominantly
Chinese. Based on this population size, in order to detect
margin of error of 5%, with a confidence level of 95% and a
response distribution of at least 50%, a minimum sample
size of 383 subjects had to be recruited (Raosoft® Sample
size calculator software, Raosoft Inc., US). In this study, the
available sample size for statistical analysis was 408 subjects
although a total of 481 subjects were recruited in the begin-
ning, owing to blood insufficiency, low concentration of
extracted DNA, insufficient remaining DNA sample, miss-
ing data, and duplicate cases. The ethnicities of the sub-
jects were self-identified in three given choices: Malay/
Peninsular Bumiputera (Orang Asli), Chinese, or Indian.
The subjects (169 men, 239 women; 190 obese, 218 non-
obese) had a mean age of 52.4 ± 13.7 years and comprised
148 Malays, 177 ethnic Chinese, and 83 ethnic Indians. They
were unrelated subjects visiting the Kampar Health Clinic
who had fasted overnight prior to the blood collection. Sub-
jects with known medical conditions such as hyperthyroid-
ism, pituitary diseases, chronic liver or renal diseases,
acute infection, and hematologic diseases were excluded
from the study. Other exclusion criteria were pregnancy,
patients undergoing dialysis, body builders or highly
trained athletes, people with a fever or swelling, and pa-
tients with osteoporosis who have very low bone density.
Anthropometric measurements (systolic and diastolic
blood pressures (SBP and DBP, respectively), waist and hip
circumference (WC and HC, respectively), weight, height
and body compositions such as total body fat (TBF), sub-
cutaneous fat (SF), visceral fat level (VFL), resting metab-
olism (RM), and skeletal muscle percentage (SM)) were
obtained from subjects as previously described [6]. Sub-
jects with a body mass index (BMI) of 27 kg/m2 were con-
sidered as obese [7].
This study was registered under the National Medical
Research Registry (NMRR-09-826-4266) and the proto-
col was approved by the Medical Research and Ethnics
Committee, Ministry of Health Malaysia. All subjects
participating in this study signed informed consent
forms and all samples were taken in accordance with the
Declaration of Helsinki (revised in Seoul, 2008).
Genotyping
Genomic DNA was extracted from the leucocytes using
Wizard® Genomic DNA Purification Kit (Promega Inc.,
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protocol. PCR-RFLP was performed according to the con-
ditions adapted from previous studies [8-10]. The prod-
ucts were electrophoresed on agarose gel (2% for the LEP
variants or on 3% for LEPR SNPs). PCR products of three
samples with known genotype from each SNP were veri-
fied by direct DNA sequencing (First BASE Laboratories
Sdn. Bhd., Malaysia).Plasma leptin level determination
Plasma leptin level (PLL) was determined using com-
mercially available enzyme-linked immunoabsorbent assay
(ELISA) kit (Assaymax Human Leptin ELISA kit, Assaypro,
USA) according to the manufacturer’s instructions.Statistical analysis
The data were analyzed using Statistical Package for
Social Sciences (SPSS) for Windows® Version 17.0 (SPSS
Inc, Chicago, IL, USA). Allelic frequencies for each SNP
were estimated by gene counting and the distribution of
genotypes was tested for Hardy-Weinberg equilibrium
using the Chi-square (χ2) test. Data for continuous vari-
ables were presented as means ± standard deviations (SD)
or adjusted means ± standard error of the mean (SEM)
and as frequency for categorical variables. The normality
of distributions of continuous variables was tested with
the Kolmogorov-Smirnov test and variables that were not
distributed normally were log-transformed prior to statis-
tical analysis. Genotype and allele frequencies of the SNPs
with respect to BMI status, gender, and ethnicity were
assessed for association using χ2 test while Student’s t test
or analysis of covariance using general linear model (ad-
justed for ethnicity) were performed for continuous vari-
ables. A P value of less than 0.05 was considered to be
statistically significant.
Statistical power calculation was performed to ensure
the study has adequate sample size to detect the asso-
ciation of genetic variants and obesity and its related
traits by using Quanto version 1.2.4 (http://biostats.
usc.edu/Quanto.html). The statistical power was set to
be 80% (two-sided) at 5% level of significance. Based on
the required parameters, the minimum number of sub-
jects needed to achieve 80% power would be 130, 124,
126, and 142 for LEP A19G, LEP G2548A, LEPR K109R,
and LEPR Q223R, respectively. These sample sizes in the
present study were more than adequate when the subjects
were analyzed as a whole or separately according to their
ethnicity, except for Indians. In this study, there were 148
Malays, 177 Chinese, and 83 Indians. For Indians, their
sample size of 83 subjects would only achieve 57% to
63% power for all four SNPs. The overall sample size of
408 subjects in this study would achieve a statistical power
of 99%.Results and discussion
Allele frequencies and associations with obesity, ethnicity,
and gender
The variant allele frequency (VAF) for LEP A19G, G2548A
and LEPR K109R, Q223R were 0.74, 0.67 and 0.61, 0.79,
respectively. The genotype distribution of LEP SNPs,
but not LEPR SNPs, was in Hardy-Weinberg equilibrium.
The VAF for all the SNPs except for LEP G2548A were
higher than that reported by Liew et al. [11] in a sample
of Malaysian university students, which was conducted as
part of a pilot study prior to the present research. The dif-
ference in allele frequency could be attributed to the im-
balance distribution in gender and ethnicity of the pilot
study as majority of the subjects were Chinese women as
well as the fewer numbers of obese subjects recruited.
The genotype and allele frequencies of all SNPs were
not associated with obesity and gender, but with ethnicity
(Table 1). However, the frequency of LEPR 109R allele was
significantly different among gender. In accordance with
most previous studies, this study failed to find an associ-
ation between the LEP A19G polymorphism and obesity
as supported by findings in Finnish subjects [8], Italian
obese patients [12], Brazilians of European descent [13],
Caucasians [14], and an African tribal population group
[15]. The LEP A19G variant (rs2167270) is a single base
transition from A→G at nucleotide position 19 in the 5′
untranslated region (UTR) of exon 1 of the LEP gene [16].
As this variant is located within the first untranslated exon
of the gene, it is not known how such an alteration might
modify protein function [17]. Nevertheless, it has been
proposed that this SNP is in disequilibrium with promoter
region variation that may have an effect on gene transcrip-
tion [18]. However, the mechanisms of how the DNA se-
quence variability in the promoter region influences
promoter activity or gene expression are still less clear
and merit further investigation.
According to Li et al. [19], this LEP G2548A variant
was more common in Caucasians than African-Americans
within the average-weight groups. The present study
found that the variant A allele was higher in Asians,
at least among Malays/Peninsular Bumiputras, Chinese,
and Indians. Numerous studies have failed to detect an as-
sociation between this genetic variant and obesity as sup-
ported by research among Tunisians [20], Pacific Islanders
[21], Spanish [22] and Africans [15]. The LEP G2548A
SNP (rs7799039) is a G→A transition at nucleotide pos-
ition -2548 upstream of the ATG start site in the LEP gene
5′ promoter region [23]. According to Jiang et al. [24],
since the LEP G2548A polymorphism is not at a con-
served region among human, mouse, and rat species, its
functional significance is uncertain. On the other hand,
this polymorphism is located at the 5′ end of the pro-
moter region of LEP [25]. It has been postulated that this
remote region might contain inhibitory elements for
Table 1 Genotype and allele frequencies of LEP and LEPR SNPs according to BMI status, ethnicity, gender
SNP/Genotype/Allele Obesity status Ethnicity Gender
Non-obese Obese Malay* Chinese Indian Male Female
LEP A19G
AA 12 10 4 11 7 9 13
AG 88 79 52 73 42 63 104
GG 118 101 92 93 34 97 122
P 0.968 0.024 0.430
A 112 99 60 95 56 81 130
G 324 281 236 259 110 257 348
P 0.906 0.006 0.299
LEP G2548A
GG 28 20 14 17 17 24 24
GA 81 89 59 67 44 62 108
AA 109 81 75 93 22 83 107
P 0.140 0.001 0.167
G 137 129 87 101 78 110 156
A 299 251 209 253 88 228 322
P 0.443 < 0.001 0.978
LEPR K109R
KK 43 41 27 6 51 28 56
KR 75 76 63 60 28 62 89
RR 100 73 58 111 4 79 94
P 0308 < 0.001 0.169
K 161 158 117 72 130 118 201
R 275 222 179 282 36 220 277
P 0.174 < 0.001 0.040
LEPR Q223R
QQ 14 14 7 4 17 6 22
QR 58 59 49 40 28 50 67
RR 146 117 92 133 38 113 150
P 0.524 < 0.001 0.084
Q 86 87 63 48 62 62 111
R 350 293 233 306 104 276 367
P 0.269 < 0.001 0.093
All values by Chi-square test, significant at P < 0.05 and indicated in bold font.
LEP, leptin; LEPR, leptin receptor; SNP, single nucleotide polymorphism. aMalay/Peninsular Bumiputra.
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polymorphism is close to these elements and putative bind-
ing sites, the effect of this SNP on leptin expression remains
to be investigated.
The higher VAF for LEPR K109R found in this study
was confirmed by recent findings of a systematic review
and meta-analysis by Bender et al. [27]. According to
them, there was a strong difference in allelic frequencies
between Caucasians and Asians, with Asians showing
much higher derived allele frequencies for 109R (76.5%
to 84.4% compared to 12.3% to 35.3% in Caucasians). Inthis study, the genotype and allele distribution of LEPR
K109R were found to be associated with ethnicity. Simi-
larities were observed in the VAF of this SNP among
subjects of the same ethnic backgrounds; specifically eth-
nic Indians and Chinese in this study with Chinese and
Indian nationals. Among ethnic Indians, the VAF was 0.22;
in agreement with 0.21 in a study by Murugesan et al. [28]
which consisted of a local population in Coimbatore,
with majority being Tamil Nadu Indians. Indeed, majority
of Malaysian Indians in this study comprises of Tamils
and Telugus with ancestries tracing back to the Indian
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Chinese was 0.80, in line with 0.81 among Chinese popu-
lation as reported recently by Lu et al. [30]. The subjects
in Lu et al.’s study were a population of Han Chinese in
Shanghai while the Malaysian Chinese subjects in this
study comprises mostly of Han Chinese descent. It has
been documented that Chinese migrants predominantly
originated from Han Chinese from the southern provinces
of China, such as Guangdong and Fujian [31]. Therefore,
the similar VAF found between both ethnic groups in
Malaysia and those in China and India reflect the genetic
ancestral origins based on their migration history. With
regard to Malays, observation cannot be made as no pub-
lished data are available for comparison.
The LEPR K109R SNP (rs1137100) is an A→G transi-
tion in codon 109 (AAG to AGG) at position 326 in exon
4. This causes a conservative change that resulted in a
change of amino acid lysine to arginine (Lys/K to Arg/R)
[10]. Although this alteration produces amino acid changes
and hence may have functional consequences, its change
in functionality is not evident. No actual evidence of the
possible functional implications of nucleotide alterations
in LEPR is available and yet it is likely that these variants
serve as genetic markers for nearby functional variants
which are in linkage disequilibrium with selected
markers [32]. Interestingly, as an alternative explanation
for variation in allele frequency, Hancock et al. [33] re-
ported that associations of some LEPR variants (which in-
cludes K109R) with climate variables, indicating a role of
climate adaptations in the biological mechanisms under-
lying metabolic phenotypes such as cold adaptation and
overweight. The researchers suggest that variants such as
LEPR K109R are deleterious in hot equatorial climates
might be advantageous in colder climates. According to
them, LEPR K109R is one of the best examples to illus-
trate the relationship between genetic susceptibility to
metabolic disorders and climate adaptations.
The VAF for LEPR Q223R reported in the present
study supports previous findings of much higher derived
allele frequencies for 223R in Asians (80.6% to 95.0%
compared to 30.2% to 56.7% in Caucasians) [27]. Indeed,
evidence for recent positive natural selection of variants
in polymorphic genes including LEPR Q223R was de-
scribed in the major ethnic groups globally, among them
Asian populations [34]. It was demonstrated that in
many of the putatively selected regions, there is a signifi-
cant over-representation of genes associated with com-
plex diseases. The present results are in agreement with
previous studies which reported non-association with
obesity [10,35,36]. However, conflicting results were also
reported as this SNP was found to be associated with
obesity [13,37,38]. The LEPR Q223R SNP (rs1137101) is
an A→G transition that causes a non-conservative
change which converts a glutamine to an arginine (Gln/Qto Arg/R) in codon 223 (CAG to CGG) at position 668
in exon 6 [10]. LEPR Q223R SNP results in changes
in charge (neutral to positive) and is located within the
leptin-binding region in the extracellular domain of the
LEPR gene. Thus, changes in amino acid affect all iso-
forms of the receptor and may be linked to impaired sig-
naling capacity. The fact that LEPR Q223R polymorphism
in human resembled Q269P mutation in Zucker rat model
in terms of proximity and similarity may possibly explain
the leptin resistance in human as a result of profound
changes in its signaling pathways [37].
Since the distribution of genotypes and alleles of LEP
and LEPR SNPs were significantly different between eth-
nicities, a separate analysis based on ethnicity was per-
formed. This is to assess its association within each ethnic
group as earlier analyses were carried out on a heteroge-
neous mix of subjects. Within the Malay, Chinese, and
Indian ethnic group, there was no significant association
between the allele frequencies of all the four SNPs studied
and obesity (data not shown). Similarly, the allele frequen-
cies of the SNPs studied were found to be not associated
with genders among the Malays and Chinese, respect-
ively. However, among Indians, an association was found
between the LEPR Q223R allele frequency and genders
while no such association was observed for the three
other SNPs.
Taken together, these findings demonstrate that it is
difficult to explain obesity on the basis of common poly-
morphisms in the human LEP and LEPR genes. Possible
predisposition to obesity due to different combination of
allelic variants from different genes can obscure differ-
ences in genotype and allele frequencies between normal
and obese subjects, especially when comparison is being
done one gene at a time [39]. The absence of association
might not necessarily suggest a lack of effect, instead it
reflects the complex pathogenesis of obesity which com-
prises environmental factors in addition to genetic com-
ponent [40].
Associations with anthropometric and clinical variables
All the anthropometric and clinical variables assessed
were not significantly different among alleles of LEP
A19G and G2548A (Table 2). This result is in line with a
previous study [8] which reported that LEP A19G was
not associated with any obesity-related variables evaluated,
including weight, BMI, fat mass (FM), waist-to-hip ratio
(WHR), respiratory quotient, and basal metabolic rate.
Likewise, no such association with common obesity-related
variables (BMI, FM, WC, WHR, metabolic parameters,
and blood pressures) was reported in Romanian [22] or
Polish subjects in relation to LEP G2548A [41]. This SNP
seems to have no effect on the wide range of anthropo-
metric indicators of obesity, at least among the sampled
Malaysian population.





LEP A19G LEP G2548A LEPR K109R LEPR Q223R
Alleles Alleles Alleles Alleles
A G P G A P K R P Q R P
SBP (mmHg) 137.56 ± 1.47 140.05 ± 0.87 0.146 139.75 ± 1.32 139.24 ± 0.91 0.751 141.85 ± 1.21 137.84 ± 0.96 0.010 144.00 ± 1.62 138.17 ± 0.84 0.001
DBP (mmHg) 80.53 ± 0.74 81.27 ± 0.43 0.387 81.79 ± 0.66 80.74 ± 0.45 0.187 82.06 ± 0.60 80.45 ± 0.48 0.040 82.08 ± 0.81 80.81 ± 0.42 0.166
Pulse rate (bpm) 73.32 ± 0.90 74.32 ± 0.53 0.335 73.74 ± 0.80 74.22 ± 0.56 0.621 75.14 ± 0.74 73.88 ± 0.59 0.065 74.98 ± 0.99 73.82 ± 0.51 0.298
WC (cm) 90.52 ± 0.80 91.16 ± 0.47 0.488 91.10 ± 0.71 90.95 ± 0.50 0.862 92.95 ± 0.65 89.74 ± 0.52 < 0.001 92.43 ± 0.88 90.61 ± 0.46 0.068
WHR 0.89 ± 0.01 0.90 ± 0.003 0.231 0.90 ± 0.01 0.89 ± 0.003 0.341 0.90 ± 0.004 0.89 ± 0.004 0.039 0.89 ± 0.01 0.89 ± 0.003 0.973
Weight (kg) 69.29 ± 1.02 69.87 ± 0.60 0.625 70.11 ± 0.91 69.54 ± 0.63 0.611 71.42 ± 0.84 68.63 ± 0.67 0.010 70.95 ± 1.13 69.39 ± 0.58 0.223
BMI (kg/m2) 27.01 ± 0.35 27.22 ± 0.20 0.606 27.15 ± 0.31 27.18 ± 0.21 0.940 28.05 ± 0.28 26.60 ± 0.23 < 0.001 27.85 ± 0.38 26.99 ± 0.20 0.047
TBFa (%) 33.27 ± 0.48 33.31 ± 0.28 0.740 33.29 ± 0.43 33.31 ± 0.30 0.808 34.46 ± 0.39 32.56 ± 0.31 0.001 34.70 ± 0.53 32.93 ± 0.27 0.007
SFa (%) 27.36 ± 0.57 27.14 ± 0.33 0.904 27.14 ± 0.50 27.22 ± 0.35 0.913 28.72 ± 0.46 26.22 ± 0.37 < 0.001 28.87 ± 0.62 26.75 ± 0.32 0.005
VFLa (%) 11.79 ± 0.43 12.44 ± 0.25 0.188 12.16 ± 0.38 12.32 ± 0.27 0.636 13.06 ± 0.35 11.76 ± 0.28 0.006 12.92 ± 0.47 12.09 ± 0.25 0.076
RM (kcal) 1448.53 ± 18.06 1459.04 ± 10.63 0.617 1462.09 ± 16.09 1453.54 ± 11.16 0.663 1468.24 ± 14.83 1448.68 ± 11.82 0.308 1457.77 ± 19.95 1455.94 ± 10.31 0.935
SMa (%) 25.09 ± 0.28 25.05 ± 0.17 0.919 25.19 ± 0.25 24.99 ± 0.17 0.536 24.58 ± 0.23 25.36 ± 0.18 0.005 24.39 ± 0.31 25.24 ± 0.16 0.010
Leptina (ng/mL)b 33.48 ± 39.10 27.31 ± 35.29 0.325 32.40 ± 37.75 27.22 ± 35.63 0.053 32.34 ± 42.21 26.70 ± 31.96 0.010 30.06 ± 36.68 28.60 ± 36.34 0.058
All values by univariate analysis of variance (General Linear Model) and adjusted for covariate ethnicity, significant at P < 0.05 and indicated in bold font. Values presented as adjusted mean ± SEM (estimated marginal
means ± standard error of the mean).
aValues were log transformed before analysis.
bLeptin values were analyzed by Student’s t-test and presented as mean ± SD (standard deviation).
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lele showed a significant trend of higher means for blood
pressures and all anthropometric measurements, except
for pulse rate and RM but lower SM. These results are
in accordance with a number of studies but in contrast
to many others. Rosmond et al. [42] found that variant
R homozygotes had lower SBP (10.0 mmHg) and DBP
(7.8 mmHg), BMI, and abdominal sagittal diameter. This
observation is in agreement with the present study
where carriers of R allele also showed lower blood
pressures (SBP and DBP) and BMI. However, the small
differences detected for SBP (4.01 mmHg) and DBP
(1.61 mmHg) may not be of clinical significance. Lu et al.
[30] also reported that KK homozygotes had higher SBP
in men but this variant was not associated with obesity-
related traits (weight, BMI, WC, WHR, insulin, lipids, uric
acid, and DBP).
The anthropometric measurements evaluated in this
study were not significantly different between the alleles
of LEPR Q223R with the exception of SBP, BMI, TBF, SF,
and SM. Carriers of the variant R allele had significantly
lower mean SBP of 5.83 mmHg and mean BMI of 0.86
units compared to those with wild-type Q allele. With
respect to blood pressures, this is in agreement with
findings by Rosmond et al. [42], which found that RR
homozygotes also exhibited lower SBP and DBP (7.6 and
5.7 mmHg, respectively) compared to QQ homozygotes,Table 3 The relationship between genotype combinations wi
leptin levels
Variable M
Subjects homozygous for all four SNPsa
(n = 70)
SBP (mmHg) 137.40 ± 19.83
DBP (mmHg) 81.55 ± 10.51
Pulse rate (bpm) 74.48 ± 12.60
WC (cm) 90.94 ± 12.50
HC (cm) 101.20 ± 11.09
WHR 0.90 ± 0.08
Height (cm) 161.11 ± 8.54
Weight (kg) 70.38 ± 16.34
BMI (kg/m2) 27.04 ± 5.57
TBFb (%) 31.92 ± 6.53
SFb (%) 25.25 ± 7.84
VFLb (%) 12.64 ± 6.87
RM (kcal) 1,491.96 ± 282.82
SMb (%) 25.78 ± 3.82
Leptinb (ng/mL) 21.22 ± 27.96
All values by Student’s t-test, significant at P < 0.05 and indicated in bold font.
aSubjects with homozygous mutated genotypes for all four SNPs: GG for LEP A19G,
bValues were log transformed before analysis.while no association was found for BMI, WHR, and ab-
dominal sagittal diameter. According to the researchers,
this result suggests that leptin induces hypertension through
the leptin receptor by activation of central sympathetic
nervous system and therefore it is postulated that hyper-
tension is absent with a malfunction central leptin recep-
tor. In this study, it was found that carriers of Q allele had
higher adiposity indices (BMI, TBF, and SF). Similarly, QQ
homozygotes had on average 64 cm2 more total abdom-
inal fat than those carrying R allele [43].
Nevertheless, present results of wild-type LEPR K109
allele carriers with higher adiposity indices (WC, WHR,
weight, BMI, TBF, SF, and VFL) but lower SM than car-
riers of variant R allele indicates predisposition to cen-
tral obesity with higher fat levels and lower muscle mass
in those carrying the wild-type allele rather than variant
allele. The same observation was seen with the wild-type
LEPR Q223 allele (higher adiposity indices of BMI, TBF,
and SF). This would explain even though these variants
(R allele in both SNPs) are prevalent in the sampled popu-
lation (VAF of 0.61 for LEPR K109R and 0.79 for LEPR
Q223R), no significant association with obesity was found.
Since these variants are known to be in higher frequency
in Asians compared to other populations, it appears that
the sequence variation were in favor (or detrimental) to
them in this context some 6,000 to 8,000 years ago
[27,44]. As this period coincides with the introduction ofth blood pressures, anthropometric variables, and plasma
ean ± SD
Subjects not homozygous for all four SNPs P
(n = 338)
139.83 ± 22.23 0.398
80.98 ± 10.78 0.688
73.98 ± 13.10 0.768
91.01 ± 11.51 0.966
102.13 ± 9.91 0.484
0.89 ± 0.08 0.457
159.81 ± 9.39 0.283
69.59 ± 14.63 0.686
27.20 ± 5.00 0.813
33.59 ± 6.98 0.131
27.60 ± 8.20 0.045
12.19 ± 6.23 0.672
1,448.95 ± 258.76 0.214
24.91 ± 4.08 0.084
30.50 ± 37.77 0.015
AA for LEP G2548A, RR for both LEPR K109R and LEPR Q223R.
Fan and Say Journal of Physiological Anthropology 2014, 33:15 Page 8 of 10
http://www.jphysiolanthropol.com/content/33/1/15agriculture in Asia, it is hypothesized that the LEPR gene
could be considered a ‘thrifty’ gene, which promotes better
fat storage during food abundance and ensuring survival
during periods of famine [45].
With respect to PLL, the influence of LEP A19G and
G2548A and LEPR Q223R SNPs, in the present study
was not evident; consistent with studies that found no
association in LEP A19G [12,14], LEP G2548A [14,15],
and LEPR Q223R [41,42]. For LEPR K109R SNP, carriers
of K allele had higher PLL of 5.64 ng/mL, in agreement
with a study by Wauters et al. [43], where the KK homozy-
gotes exhibited higher PLL than R carriers in a small sub-
group of post-menopausal women. However, the recessive
effect of the R allele was also observed, where carriers of
the R allele of LEPR K109R gene showed increased PLL
compared to non-carriers in weight gainers among young
Dutch adults [46]. Despite these discrepancies, this implies
the existence of genotype-specific effects in the coordin-
ation of circulating leptin with regard to active fat depos-
ition [47]. In support of this, a functional study described
that this common polymorphism of LEP G2548A influ-
enced leptin expression and consequently alter plasma lep-
tin levels, possibly at the transcriptional level [48].
Relationships between genotype combinations with
anthropometric and clinical variables
Mutations in the mouse LEP gene homozygous for the
ob/ob phenotype resulted in the absence of leptin pro-
duction. However, the homologous mutation in the LEP
gene in humans has not been reported [49]. The LEP
gene sequence is highly conserved, being 84% identical
with the mouse protein [50]. The first case of human
mutation in the leptin gene was reported in 1997 for
homozygous frameshift mutation in two children with
the same consanguineous pedigree [51]. Severe obesity
due to single mutation in the LEP gene is so rare that
only 12 human cases were reported to date [52]. On the
other hand, the db/db and Zucker fa/fa mutations in
chromosome 4 of the mouse cause severe obesity which
is irreversible by leptin treatment. The human LEPR
gene is 78% homologous to the mouse gene [53]. Hence,
the severity of phenotype caused by LEPR mutations in
human would be similar to those observed in mouse
models. However, similar to leptin, such mutations are
very infrequent in humans. Instead, LEPR variants which
do not cause such extreme loss of function are more
commonly reported [54]. When analyzed individually,
only certain SNPs were associated with some of the
obesity-related traits such as blood pressures, anthropo-
metric variables, and PLL.
However when analyzed together, it is interesting to
note that subjects homozygous for all four SNPs studied
exhibited significantly higher SF and PLL than those
with other genotype combinations (Table 3). To the bestof our knowledge, the synergistic effect of these LEP and
LEPR genotype combinations on SF and PLL has not been
reported elsewhere previously. In a Chinese population, Lu
et al. [30] found that a combination of SNPs in the LEP
gene 3′ flanking region, LEPR K109R and LEPR K656N is
associated with significantly higher BMI. According to
Bouchard et al. [55], the contribution of a single gene may
not necessarily cause a significant phenotypic variance.
However, in combination, they may account for a signifi-
cant part of the variation, leading to predisposition to
obesity. This is particularly true for a polygenic disease
such as obesity, where a single gene polymorphism is likely
to exert a minor influence on the observed phenotype.
Study limitations
Inconsistency of the results from this study may be due
to sample size, sampling method, and restriction to a
certain area which could have a risk of sampling bias.
With regard to the moderate size of the screened popu-
lation, future studies should involve larger sample size of
Malaysians from all the states with a more balanced age
groups, ethnicities, and genders to better reflect the Ma-
laysian population. Another limitation is this study did
not take into account certain variables found by previous
studies to be significantly associated with LEP and LEPR
SNPs such as biochemical parameters like serum lipids,
glucose, and insulin. Hence, the impacts of these param-
eters should be considered in future studies.
Conclusions
The present results show that LEP A19G, LEP G2548A;
LEPR K109R and LEPR Q223R SNPs are unlikely to be a
relevant obesity marker among Malaysians, at least among
the Kampar suburban population, but were associated with
ethnicity. Findings from this study suggest that each of
these SNPs contributes to minor but significant variation
in obesity-related phenotypes. The LEPR K109R gene vari-
ants also influence PLL in Malaysian subjects. Synergistic
effect of LEP and LEPR genotype combinations on SF and
PLL was observed.
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